BACKGROUND: Innate antigen-presenting cells and adaptive immune T cells have been implicated in the development of hypertension. However, the T-lymphocyte subsets involved in the pathophysiology of hypertension remain unclear. A small subset of innate-like T cells expressing the γδ T cell receptor (TCR) rather than the αβ TCR could play a role in the initiation of the immune response in hypertension. We aimed to determine whether angiotensin (Ang) II caused kinetic changes in γδ T cells; deficiency in γδ T cells blunted Ang II-induced hypertension, vascular injury, and T-cell activation; and γδ T cells are associated with human hypertension.
H igh blood pressure (BP), or hypertension, is the leading risk factor for global disease burden. 1 Hypertension is associated with vascular injury that results in increased vascular resistance, which contributes to further development of hypertension and end organ damage. 2 Both innate (such as monocyte/macrophages) and adaptive immune cells (such as T lymphocytes) have been shown to play an important role in the development of hypertension and vascular damage. 3, 4 Adventitial and perivascular adipose tissue monocyte/macrophage and T-cell infiltration has been consistently observed in animal models of hypertension. We have shown that angiotensin (Ang) II-and deoxycorticosterone acetate/salt-induced hypertension and vascular injury were blunted in osteopetrotic mice that have a mutation within the macrophage colony-stimulating factor gene (Csf1) and consequently a deficiency in monocyte/macrophages. 5, 6 Furthermore, it has been shown that mice with inactivation of the recombination-activating gene 1 (Rag1 -/-) responsible for the Band T-cell receptor (TCR) V(D)J recombination, which lack T and B lymphocytes, presented a blunted response to Ang II-and deoxycorticosterone acetate/salt-induced hypertension and vascular injury. This finding was reversed by adoptive transfer of T but not B cells. 7 TCRs are constituted of 2 different chains generated by the rearrangement of TCR genes, which give specificity for antigenic peptide recognition. [8] [9] [10] [11] T cells could be separated into 2 families based on the TCR chain constitution. Most of the T cells (96% to 99%) express α and β TCR chains (αβ T cells), whereas a small population of T cells (1% to 4%) express γ and δ TCR chains (γδ T cells). CD4
+ and CD8 + αβ T cells recognize antigenic peptides presented by antigen-presenting cells by their major histocompatibility complex-II and -I, respectively. However, γδ T cells, which are mostly CD4 and CD8 double negative, are unconventional T lymphocytes with rapid innatelike responses that position them in the initiation phase of the immune reaction. γδ T cells are activated by nonprotein phosphoantigens, isoprenoid pyrophosphates, alkylamines, nonclassic major histocompatibility complex class I molecules, major histocompatibility complex class I chain-related proteins A and B, as well as heat shock protein-derived peptides without antigen processing and major histocompatibility complex presentation. Interestingly, Guzik et al 7 have observed that the number of aortic-infiltrating double negative T cells and the percentage of peripheral blood double negative T cells were increased in Ang II-infused mice. However, it is unknown whether γδ T cells contribute to the development of hypertension and vascular injury.
We hypothesized that γδ T lymphocytes play a key role in the development of hypertension, vascular injury, and inflammation. To test this hypothesis, we first determined the kinetic changes in frequency and number of total and activated γδ T cells during Ang II infusion and then tested whether Ang II-induced hypertension and vascular injury would be blunted in Tcrδ −/− mice devoid γδ T cells and in mice depleted of γδ T cells by depleting antibody injections. We also determined whether Ang II-induced T-cell activation in the spleen and perivascular adipose tissue was blunted in Tcrδ −/− mice. Next, we investigated whether Ang II-induced T-cell activation would be blunted in the absence of γδ T cells. Last, we evaluated whether γδ T cells are associated with human hypertension.
METHODS
A detailed Methods section is provided in the online-only Data Supplement.
Experimental Design
The study was approved by the Animal Care Committee of the Lady Davis Institute and McGill University and followed recommendations of the Canadian Council of Animal Care. Fourteen-to 15-week-old male C57BL/6J male TCR δ constant region null mice (renamed Tcrδ −/− ), which are devoid of γδ T cells, 12 and wild-type (WT) C57BL/6J mice were obtained from Jackson Laboratories. Mice were infused or not subcutaneously with Ang II (490 ng/kg/minute) using ALZET osmotic minipumps (Model 1002, Durect Corporation) for 3, 7, or 14 days as previously described. 13 Control mice underwent sham surgery. Furthermore, a group of mice was anesthetized with isoflurane and surgically instrumented with PA-C10 telemetry transmitters, and BP was determined for 2 consecutive days before and during the 14-day treatment period. Second-order mesenteric arteries were used for assessment of endothelial function and mesenteric artery perivascular adipose tissue and spleen for immune cell profiling by flow cytometry ( Figure I and What Are the Clinical Implications?
• Understanding the role of γδ T cells in modulating immune responses will help design novel treatments to limit the progression of hypertension and vascular damage.
antibody (BioXCell) 1 day before and 6 days after the initiation of Ang II infusion.
To determine the relevance of γδ T cells in human hypertension, the whole blood gene expression microarray data of patients with and without coronary artery disease (CAD) 14 were used to demonstrate an association between the frequency of γδ T cells in peripheral blood and SBP.
Data Analysis
Results are presented as means±SEM or SD as indicated in the table or figure legends. BP and concentration-response curve data were compared by 2-way analysis of variance for repeated measurements with SigmaPlot version 13 (Systat Software). Comparisons among multiple groups for other data were analyzed by 1-or 2-way analysis of variance as needed. Analysis of variance tests were followed by a Student-Newman-Keuls post hoc test. Correlation between SBP and expression of each TCR γ constant regions (TRGC) 1 and 2 probe set was done by univariate correlation analyses and partial correlation analyses corrected for age and sex with or without the presence of CAD. Next, we used multiple linear regression (MLR) to model SBP using all 4 TRGC1/2 probe sets (model 1), age and sex (model 2), all 4 TRGC1/2 probe sets, age, and sex (model 3), and all 4 TRGC1/2 probe sets, age, sex, and CAD (model 4) to further demonstrate the association between SBP and peripheral γδ T-cell frequency. Univariate and partial correlations as well as multiple linear regression modeling were done using IBM SPSS statistics version 23.0 (IBM Corporation). Models were compared using a Likelihood ratio test in R version 3.2.3 (https://www.r-project.org/). P<0.05 was considered statistically significant. Figure 1A and B) . As expected, γδ T cells were mostly double negative (≈80%; Figure II in the online-only Data Supplement). Furthermore, small populations of γδ T cells were CD8 + (10% to 14%), CD4 + (5% to 10%), and CD4 + CD8 + (2% to 3%). Only 1 small population of γδ T cells, CD4 + γδ T cells, increased 6% to 9% after 7 days of Ang II. However, this finding does not explain the Ang II-induced 40% rise of the whole population of γδ T cells. However, the investigation of activated γδ T cells using the CD69 marker showed that the frequency of CD69 + γδ T cells tended to be greater and was 1.4-fold higher after 7 and 14 days of Ang II infusion, respectively, whereas the number of CD69 + γδ T cells was increased >2-fold after 7 and 14 days of Ang II infusion ( Figure 1C and D).
γδ T Cells Play a Role in Hypertension and Vascular Dysfunction
The importance of γδ T cells in hypertension and vascular dysfunction was first tested using Tcrδ −/− mice deficient in γδ T cells. Fourteen days of Ang II infusion caused a 44 mm Hg increase in SBP in WT mice, which was blunted in Tcrδ −/− mice ( Figure 2A ). Ang II infusion induced endothelial dysfunction as demonstrated by a 37% reduction in the vasodilatory response to acetylcholine in WT mice. Impairment of acetylcholine-induced relation was blunted in Tcrδ −/− mice ( Figure 2B ). Impaired endothelial vasodilatory response was not the result of a vascular smooth muscle cell defect because endothelium-independent relaxation responses to the nitric oxide donor sodium nitroprusside were similar in all groups ( Figure IIIA in the online-only Data Supplement).
Additional proof of a role of γδ T cells in hypertension and vascular dysfunction was obtained using mice depleted of γδ T cells by injection of an anti-γδ TCR antibody. The frequency of γδ T cells was slightly decreased in mice injected with a control isotype IgG antibody and almost completely depleted in mice injected with a γδ T cell-depleting antibody compared with mice not injected with antibodies ( Figure IV in the online-only Data Supplement). Fourteen days of Ang II infusion caused a 40 mm Hg increase in SBP in control antibody-injected mice, whereas the SBP rise was reduced by 50% in γδ T-cell-depleting antibody-injected mice ( Figure 2C ). The vasodilatory response to acetylcholine was normal in γδ T-cell-depleting antibody-injected mice, whereas it was impaired in control antibody-injected mice ( Figure 2D ). The vasodilatory responses to sodium nitroprusside were similar in both groups ( Figure  IIIB 
γδ T Cells Are Relevant to Human Hypertension
The potential participation of γδ T cells in human hypertension was assessed by demonstrating an association between γδ T-cell frequency in blood and SBP. This was achieved using the whole blood gene expression microarray and clinical data from a case population of patients with CAD and a control population without evidence of CAD, both of which included normotensive and hypertensive subjects.
14 Demographic data, medical history, and medication of this cohort have been previously described.
14 Two hundred and six out of 241 subjects with both SBP and gene expression data were included in the analyses. Baseline characteristics of these subjects are presented in Table II in the online-only Data Supplement. The expression levels of the microarray probe sets (Table III in the online-only Data Supplement) corresponding to the TRGC1 and TRGC2 (TRGC1/2) genes were used as an estimate of the frequency of γδ T cells in the blood to determine the association between γδ T cells and SBP. In univariate analysis, the expression levels of 2 TRGC1/2 probe sets out of 4 were found to correlate with SBP with coefficients of determination R 2 = 0.02 (Table) . Because it is well known that age and sex play important roles in blood pressure regulation, and given that this cohort contains patients with CAD, although the control and CAD groups have no difference in SBP (Table II in the online-only Data Supplement), we then performed partial correlation analysis corrected for age and sex or age, sex, and CAD, which both showed similar results compared with the univariate test (Table) . Next, we combined all 4 TRGC1/2 probe sets in MLR to model SBP (model 1). A correlation with R 2 =0.06 was observed between the modeled SBP and actual SBP ( Figure 4A ). A similar level of correlation (R 2 = 0.06) was observed when age and sex (model 2) were used in the MLR model (Figure 4B ). When we included the 4 TRGC1/2 probe sets together with age and sex (model 3), it significantly improved the correlation (R 2 =0.12; Figure 4C ), which was confirmed by a likelihood ratio test comparing models 2 and 3 (P<0.01). We next added CAD on top of model 3 to build model 4, which yielded a similar result (R antibody zebra plots are shown. Data are presented as means±SEM, n=6 to 7. Data were analyzed using 2-way analysis of variance followed by a Student-Newman-Keuls post hoc test. *P<0.01 versus WT control and †P<0.01 and † †P<0.001 versus WT + Ang II. Figure 4D) , and a likelihood ratio test showed no significant difference between models 3 and 4. Altogether, these results suggest an involvement of γδ T cells in SBP levels in this human cohort that included hypertensive subjects.
DISCUSSION
This study is the first to demonstrate the role of γδ T cells in a mouse hypertensive model with vascular injury and in human hypertension. This study demonstrated an increased number and activation of γδ T cells during the development of hypertension caused by Ang II infusion, and that deficiency in γδ T cells prevented Ang II-induced hypertension, resistance artery endothelial dysfunction, and spleen T-cell activation in mice. Last, the relevance of γδ T cells in human hypertension was demonstrated by establishing an association between γδ T-cell frequency in the blood and SBP.
The small population of γδ T cells has been characterized as unconventional T cells with rapid innate-like responses positioning them at the initiation phase of immune responses. 8 Their role in the immune system has been studied in infection and autoimmune diseases but We used the expression levels of probe sets for the T-cell receptor γ constant regions 1 and 2 (TRGC1/2) genes as an estimate of the blood fraction of γδ T cells to determine simple correlations with systolic blood pressure using univariate and partial correlation analyses corrected for sex and age with or without coronary artery disease (n=206). The expression levels of probe sets for the TCR γ constant regions 1 and 2 (TRGC1/2) genes were used as an estimate of the blood fraction of γδ T cells to determine the correlations between actual systolic blood pressure (SBP) and modeled SBP using multiple linear regression combining all 4 TRGC1/2 probe sets (model 1, A), age and sex (model 2, B), all 4 TRGC1/2 probe sets, age, and sex (model 3, C), and all 4 TRGC1/2 probe sets, age, sex, and coronary artery disease (CAD) (model 4, D). It is important to note that the likelihood ratio tests demonstrated that models 2 and 3 were significantly different (P<0.01), whereas no significant difference was found between models 3 and 4. Data are shown in absolute values, n=206.
not in hypertension. This study showed the important role of γδ T cells in the development of hypertension and endothelial dysfunction in a mouse model of hypertension using 2 different approaches: Tcrδ knockout mice and antibody-mediated γδ T-cell depletion. As proposed for innate cells in hypertension, 4 γδ T cells could be activated by neoantigens and trigger the inflammatory process by secreting the proinflammatory cytokines interleukin-17A or interferon γ, both of which play a role during hypertensive process, 15, 16 or act as antigen-presenting cells as well as priming activation of other T cells. 17 These roles are supported by the observation that deficiency of γδ T cells prevented Ang II-induced T-cell activation.
Few studies have examined the role of T lymphocytes in human hypertension. Youn 
IFNγ
+ T cells in peripheral blood mononuclear cells of patients with hypertension compared with normotensive subjects. Our study demonstrated the implication of γδ T cells in human hypertension. This was shown by establishing an association between an index of γδ T-cell frequency in the blood and SBP using data from a whole blood gene expression microarray profiling study.
14 Although modest correlations occurred between SBP and individual TRGC1/2 probe set expression levels, a stronger correlation was found when all 4 probe sets were taken together in a MLR model, which was further improved when age and sex were included.
This study presents some limitations. The original human study was designed to compare patients with or without CAD, whereas both groups included normotensive and hypertensive subjects.
14 Some of the normotensive patients had cardiac disease and were treated with antihypertensive drugs, which may have affected the frequency of γδ T cells and therefore the expression of TRGC1/2 probe sets. However, the control and CAD groups showed no difference in SBP, and correcting for CAD in the partial correlation or adding CAD in the MLR model did not significantly change the correlation. Taken together, our data suggest that γδ T cells play a role in human hypertension and may contribute to the development of hypertension and vascular injury by activating T cells.
Perspectives
This study is the first to show that γδ T cells play a role in the activation of T cells and the development of hypertension and vascular injury in mice. The study also showed that γδ T cells could participate in mechanisms contributing to human hypertension. Understanding the mechanism of action of γδ T cells in the low-grade inflammatory process associated with BP rise and vascular injury may reveal new therapeutic targets for the treatment of hypertension and vascular disease.
